A marine pharmacology seminar presentation has been developed by Dr. Mayer that covers: (1) the preclinical pipeline (marine natural products with antitumor and cytotoxic activity, as well as other pharmacological activities); (2) the clinical pipeline; and, (3) FDA-approved marine pharmaceuticals. This seminar presentation is being updated on a monthly basis and has been presented at the scientific meetings and universities shown below.

Mayer, A.M.S. The global marine pharmacology pipeline. Experimental Biology 2009. ASPET Symposium: A Renaissance in Marine Pharmacology: Preclinical Curiosity to Clinical Reality. New Orleans, Louisiana, April 19, 2009.

Mayer, A.M.S.  Marine Pharmacology: FDA-approved marine drugs, and the marine clinical and preclinical pipeline. Florida International University Graduate School and Marine Sciences Program. Miami, Florida, January 30, 2009.

Mayer, A.M.S.  Marine Pharmacology: A Critique of the Preclinical and Clinical Literature. University of Puerto Rico, Rio Piedras Campus, Department of Chemistry, January 28, 2008.

Mayer, A.M.S.  Marine Pharmacology: A Critique of the Preclinical and Clinical Literature. American Association of Pharmaceutical Scientists, San Diego, California. November 13, 2007.

Please email Dr. Mayer at amayer@midwestern.edu for further information. Thank you.

Copyright © 2005-2009 Midwestern University. Last Rev. 9/23/2009. Direct questions or comments to Site Coordinator